Skip to main content
QuidelOrtho Corporation (QDEL)
NASDAQ: QDEL · Real-Time Price · USD
37.48
-1.10 (-2.85%)
Nov 20, 2024, 4:00 PM EST - Market closed

QuidelOrtho Revenue

QuidelOrtho had revenue of $727.10M in the quarter ending September 29, 2024, a decrease of -2.27%. This brings the company's revenue in the last twelve months to $2.82B, down -9.74% year-over-year. In the year 2023, QuidelOrtho had annual revenue of $3.00B, down -8.21%.

Revenue (ttm)
$2.82B
Revenue Growth
-9.74%
P/S Ratio
0.89
Revenue / Employee
$396,859
Employees
7,100
Market Cap
2.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.00B-268.20M-8.21%
Jan 1, 20233.27B1.57B92.28%
Jan 2, 20221.70B36.90M2.22%
Jan 3, 20211.66B1.13B210.66%
Dec 31, 2019534.89M12.61M2.41%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Privia Health Group 1.72B
Catalyst Pharmaceuticals 460.48M
Zai Lab 355.75M
Twist Bioscience 312.97M
SpringWorks Therapeutics 135.49M
Iovance Biotherapeutics 90.86M
Janux Therapeutics 13.05M
Revenue Rankings

QDEL News

More News